An importance of vitamin D metabolites assessment in patients with impaired renal function;Význam stanovení metabolitů vitaminu D u pacientů sníženou funkcí ledvin

Vnitrni Lekarstvi

Volumn 50, Issue 7, 2004, Pages 510-518

  Sulková, Sylvie ^a,b,c   Forova M ^a   Uhrova J ^a   Zima, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

Calcidiol; Calcitriol; Chronic renal insufficiency; Parathormon; Renal osteopathy; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIFEDIOL; CALCITRIOL; CALCIUM PHOSPHATE; CREATININE; OXYGENASE; PARATHYROID HORMONE; UREA; VITAMIN D;

ACID BASE BALANCE; ADULT; AGED; ARTICLE; BONE METABOLISM; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLITE; PARATHYROID HORMONE BLOOD LEVEL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RENAL OSTEODYSTROPHY;

CALCIFEDIOL; CALCITRIOL; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; RENAL DIALYSIS; RENAL OSTEODYSTROPHY;

EID: 3142651994     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. National Kidney Foundation. K/DOQI Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am. J. Kidney Dis., 42, 2003, 3, 1-202
2. Aucella, F., Scalzulli, R. P., Gette, G. et al.: Calcitriol induces burst-forming unit-erythroid proliferation in chronic renal failure. Nephrol. Clin. Pract., 95, 2003, 121-127
3. Bartůňková, J., Sulková, S., Fučíková, T. et al.: Vliv 1,25-dihydroxycholekalciferolu na imunitní a klinický stav a na parametry fosfokalciového metabolismu dialyzovaných pacientů. Čas. Lék. čes., 129, 1990, 1102-1106
4. Block, G. A., Hulbert-Shearon, T. E., Levin, N. W. et al.: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients. A national study. Am. J. Kidney Dis., 31, 1998, 607-617
5. Cannata-Andía, J. B., Alonso, C. G.: Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol. Dial. Transplant., 17, 2002, 1875-1878
6. Coen, G., Mazzaferro, S.: Bone metabolism and its assessment in renal failure. Nephron, 67, 1994, 384-401
7. Cunningham, J.: Parathyroid physiology in uraemia. Nephrol. Dial. Transplant., 11, 1996, 3, 106-110
8. Dusso, A. S., Brown, A.: Mechanism of vitamin D action and its regulation. Am. J. Kidney, 32, 1998, 2, 13-24
9. Fořtová, M.: Parametry kostního metabolismu u pacientů s chronickým selháním ledvin. Diplomová práce, VŠCHT, Praha 2000, 90 s.
10. Fořtová, M., Sulková, S., Uhrová, J. et al.: Parametry kostního metabolismu u pacientů s různým stupněm poškození funkce ledvin. Čas. Lék. čes., 142, 2003, 2, 112-116
11. Ganesh, S. K., Stach, A. G., Levin, N. W. et al.: Association of elevated serum PO(4) Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J. Am. Soc. Nephrol., 12, 2001, 2131-2138
12. Ganong, V. F.: Přehled lékařské fyziologie, H+H, Jinočany 1995
13. Holick, M. F.: Vitamin D requirements for humans of all ages: New increased requirements for women and men 50 years and older. Osteoporos. Int. 8, 1998, 24-28
14. Merke, J., Rith, E., Boland, R.: Are recent findings on 1.25-dihydroxycholecalciferol metabolism relevant for the pathogenesis of uremia. Nephron, 42, 1986, 277-284
15. Quarles, L. D., Lobaugh, B., Murphy, G.: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J. Clin. Endocrinol. Metab., 1992, 75-145
16. Ritz, E., Schomig, M., Bommer, J.: Osteodystrophy in the millennium. Kidney Int., 56, 1999, 73, 94-98
17. Schroeder, N. J., Cunningham, J.: What's new in vitamin D for the nephrologist? (Invited comment). Nephrol. Dial. Transplant., 15, 2000, 460-466
18. Silver, J., Yalcindag, C., Sela-Brown, A. et al.: Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int., 56, 1999, 73, 2-7
19. Slatopolsky, E., Finch, J., Ritter, C.: Dietary phosphate restriction suppresses pre-pro-PTHmRNA independent of 1,25(OH)2D3 and ionized calcium in renal failure. J. Am. Soc. Nephrol., 5, 1994, 889
20. Sulková, S. et al.: Hemodialýza. Maxdorf Jessenius, Praha 2000, 693 s.
21. Sulková, S., Fořtová, M., Válek, M. et al.: Renální kostní choroba. Vnitř. Lék., 49, 2003, 5, 403-408
22. Sulková, S., Schestauberová, E., Švára, F. et al.: Možnosti úpravy nízkých hladin kalcitriolu u dialyzovaných pacientů. Osteol. Bull., 7, 2002, 26-29
23. Thomas, M. K., Lloyd-Jones, D. M., Thadhani, R. I. et al.: Hypovitaminosis D in medical inpatients. N. Engl. J. Med., 338, 1998, 12, 777-783
24. Yonemura, K., Fujimotao, T., Fujigaki, Y. et al.: Vitamin D deficiency is implicated in reduced serum albumin concentration in patients with end-stage renal disease. Am. J. Kidney Dis., 36, 2000, 337-344